|Year : 2013 | Volume
| Issue : 4 | Page : 195-198
Squash cytology of primary central nervous system lymphoma in an immunocompetent patient
Aneel Myageri1, Vandana U G1, Sateesh Melkundi2, Preetam B Patil3, Padmaja Kulkarni1
1 Department of Pathology, SDM College of Medical Sciences and Hospital, Sattur, Dharwad, Karnataka, India
2 Department of Neurosurgery, SDM College of Medical Sciences and Hospital, Sattur, Dharwad, Karnataka, India
3 Department of Radiology, SDM College of Medical Sciences and Hospital, Sattur, Dharwad, Karnataka, India
|Date of Web Publication||22-Jan-2014|
613, Manya Towers, First Floor, SDM Medical Staff Quarters, Sattur, Dharwad 580 009, Karnataka
Source of Support: None, Conflict of Interest: None
The diagnosis of primary central nervous system lymphoma (PCNSL) can be suggested by magnetic resonance imaging (MRI). Cerebral PCNSL in immunocompetent patients generally shows marked homogeneous contrast enhancement in MRI. However, confirmation of it requires demonstration of lymphoma cells in stereotactic biopsy of the lesion or in cerebrospinal fluid. In the present case, with radiologic diagnosis of glioma, complete resection of the lesion by micro-neurosurgical technique was performed. The tumor tissue was examined by squash smear, frozen section and paraffin sections. Cytologic appreciation of tumor cells as lymphoid origin in squash smears negated the other possibilities. The immunocytochemistry on squash smear and immunohistochemistry on paraffin sections confirmed the diagnosis of diffuse large B cell lymphoma of non-germinal center B cell phenotype
Keywords: Immunocytochemistry, primary central nervous system lymphoma, squash smear
|How to cite this article:|
Myageri A, VandanaU, Melkundi S, Patil PB, Kulkarni P. Squash cytology of primary central nervous system lymphoma in an immunocompetent patient. Asian J Neurosurg 2013;8:195-8
|How to cite this URL:|
Myageri A, VandanaU, Melkundi S, Patil PB, Kulkarni P. Squash cytology of primary central nervous system lymphoma in an immunocompetent patient. Asian J Neurosurg [serial online] 2013 [cited 2021 Dec 4];8:195-8. Available from: https://www.asianjns.org/text.asp?2013/8/4/195/125673
| Introductions|| |
Primary central nervous system lymphoma (PCNSL), a rare malignancy of the craniospinal axis, is fairly common in immunocompromised patients. It is also seen in immunocompetent individuals. The symptoms of PCNSL may be indistinguishable from other CNS tumors. The post-contrast characteristic enhancement in magnetic resonance imaging (MRI) of the lesion, which usually is in supratentorial periventricular location, would indicate the possibility of PCNSL. Confirmation of PCNSL however relies upon biopsy features of the lesion and ruling out previous or concurrent non-Hodgkin lymphoma or leukemia elsewhere.
We report an immunocompetent patient with PCNSL, which was diagnosed by squash cytology and later confirmed by immunohistochemistry on squash smear and paraffin sections.
| Case Report|| |
This was a case report of a 38-year-old male patient who was admitted to neurosurgery with a history of headache and neck pain since 2 months. No history of antecedent head trauma, febrile illness, photophobia, seizures or previous diagnosis of any malignancy was present. He didn't have lymphadenopathy or hepatosplenomegaly. Neurologic examination was not revelatory as no abnormality was found. His peripheral smear examination was normal. He was negative for human immunodeficiency virus (HIV).
MRI of the brain revealed a well-defined lobulated focal mass measuring 4.5 cm × 3.6 cm × 3.5 cm with extensive adjacent white matter edema in right parieto-occipital lobe causing mass effect on right lateral and third ventricle and basal ganglia region with contralateral midline shift of 9 mm. On T1-weighted images mass was isointense to gray matter [Figure 1]a. On T2-weighted and fluid-attenuated inversion recovery images, it appeared iso to mildly hyperintense [Figure 1]b. There was mild restricted diffusion. The lesion showed intense homogeneous enhancement on post contrast study [Figure 1]c and d. Small area of central necrosis was seen within the mass. MR spectroscopy revealed an elevated choline and lipid lactate. MRI findings were concluded as glioma.
|Figure 1: (a) Axial T1‑W and (b) T2‑W magnetic resonance imaging images showing solid mass in the right parieto‑occipital region with surrounding edema. (c) Post contrast axial and (d) coronal images showing intense homogenous enhancement of mass|
Click here to view
Patient underwent craniotomy for micro-neurosurgical complete resection by aspiration of the suspected glioma. Squash preparations were made from tissue received for frozen section and stained with hematoxylin and eosin. Monomorphic lymphoid tumor cells were seen without any fibrillary background [Figure 2]a. The cells had large nuclei with prominent nucleoli and scant to moderate cytoplasm. Further, lymphoid cells having a blast like appearance with cytoplasmic vacuoles were recognized better on Leishman stain [Figure 2]b. Tingible body macrophages and lymphoglandular bodies were seen. The frozen sections showed the tumor cells in sheets, but the cytologic details were not clear.
|Figure 2: (a) Discohesive monomorphic lymphoma cells without fibrillary background (squash smear, H and E, ×40). (b) Monomorphic lymphoma cells in sheets with cytoplasmic vacuole and lymphoglandular bodies (arrow heads) (squash smear, Leishman, ×40). (c) Positivity for CD 45 in the cytoplasm of lymphoma cells (squash smear, ×40)|
Click here to view
With intraoperative diagnosis of lymphoma infiltration on squash smears, on table bone marrow aspiration was done from the sternum to rule out hemopoietic malignancy in the marrow. The bone marrow smears showed normal marrow cells.
A squash unstained smear was further studied with immunocytochemistry for CD45 (with a satisfactory positive control). The smears showed cytoplasmic CD45 positivity in intact tumor cells [Figure 2]c.
The paraffin sections revealed the typical lymphoma cells displaying perivascular pattern and invading the brain [Figure 3]a and c. The starry sky appearance was also seen [Figure 3]b. The diagnosis of PCNSL was conferred. The immunohistochemical studies showed CD20 positivity [Figure 3]d in lymphoma cells while they were negative for CD3, CD10, Bcl2, Bcl6 [Figure 4]a-d and CD99. CD3 positive reactive T cells were seen amidst the lymphoma cells [Figure 4]a. The negativity of lymphoma cells for CD10, Bcl2, Bcl6 and positivity to CD20 indicate the non-germinal center B-cell phenotype.
|Figure 3: Paraffin sections showing lymphoma cells (a) in perivascular pattern and invading brain tissue (arrow head). (b) With a starry sky appearance. (c) Around the blood vessel (b) invading into adjacent brain tissue (arrow head). (d) Positive for CD20|
Click here to view
|Figure 4: Immunohistochemistry studies showing lymphoma cells. (a) Negative for CD3 while reactive T lymphocytes are CD3 positive. (b) Negative for CD10. (c) Negative for Bcl2. (d) Negative for Bcl6|
Click here to view
The final diagnosis of diffuse large B cell primary CNS lymphoma (DLBCL) was given. Post-operative contrast CT showed complete removal of the lesion and the patient received chemo and radiotherapy. MRI after 2 years follow-up showed no evidence of recurrence.
| Discussion|| |
PCNSL is rare extranodal lymphoma seen in both immunocompetent and immunocompromised patients especially those with HIV infection. The age in immunocompetent patients ranges from 2 nd to 9 th decade with most patients above 60 years. , Sarkar C and coauthors reported that in India, incidence of PCNSL is stabilized since two decades and also patients of PCNSL are decade younger compared with the western patients.  The incidence of PCNSL is declining in the HIV affected patients probably due to effective antiviral treatment  or as in India possibly due to early death by opportunistic infections.  Patients show variable symptoms but the symptoms of raised intracranial pressure and personality changes are more frequent.  Occurrence of seizures is infrequent because of deep location of the lesion in the brain.  In our study the patient was 38-year-old and had symptoms and signs suggestive of raised intracranial tension. Most PCNSLs are supratentorial periventricular cerebral lesions. On T2-weighted MRI images the lesions appear hypointense to isointense relative to gray matter.  This is because of high cellularity in lymphoma.  Herrlinger et al. opine that such clinical symptoms and radiologic findings are suggestive, but not conclusive of PCNSL.  The lesion can simulate radiologically inflammatory/infectious diseases, primary and metastatic malignancies.  According to Elder JB and Chen TC stress that enhancement along Virchow-Robin spaces is considered a highly specific feature of PCNSL.  However biopsy is required to confirm the diagnosis. , Resection of the tumor is not an accepted surgical procedure for PCNSL, because it may increase the risk of spread and the lesions are infiltrative. , Sierra del Rio et al. suggest that PCNSL is extremely sensitive to radio and chemotherapies and biopsy only is enough for pathologic diagnosis.  In our case, the patient underwent complete resection by micro-neurosurgical technique without any neurological deficits. The reason for not performing the stereotactic biopsy was that the MRI studies were suggestive of the lesion could be a glioma; the lesion was solitary and was amenable for resection; the patient was immune-competent and lymphoma was not the first diagnosis. Alιcio-Mattei et al. recommend surgery as the gold standard therapy for early excision combined with post-operative radiotherapy. 
Typical discohesive lymphoma cells with lymphoglandular bodies without fibrillary background on squash smears would help to identify the lesion as hematopoietic origin.  Ruling out of hematopoietic malignancy in bone marrow, lymphnodes and other organs is necessary to diagnose PCNSL. Post contrast typical enhancement of lesion on MRI in supratentorial periventricular area correlated with the cyto-histologic diagnosis of primary brain lymphoma. Starry sky appearance, monomorphic large tumor cells in sheets with scant cytoplasm and multiple nucleoli and perivascular pattern with no malignant lymphoid cells within the vascular lumen on paraffin sections supported the diagnosis of primary brain lymphoma. Starry sky appearance in paraffin sections in DLBCL has been documented by Makhdoomi et al. In a recent article by Yamanaka it is concluded that most PCNSLs belong to DLBCL.  The tumor cells were positive for CD45 on squash smear. Paraffin sections showed tumor cells positive for CD45, CD20 and negative for CD3, CD10, Bcl2, Bcl6 and CD99, which confirmed the diagnosis of DLBCL of non-germinal center cell origin. Ferry JA summarizes that germinal center B cell phenotype (CD10+, bcl6+ or CD 10-, bcl6+, MUM1-) form a minority in most PCNSLs.  Bcl2 over-expression in lymphoma cells indicates germinal center cell origin. Bcl2 over expression should be studied by immunohistochemistry as t (14; 18) (q32; q21) may not be associated with over expression of the bcl2 protein.  High degree of suspicion is required to diagnose PCNSL when MRI shows characteristic features and necessitates the use of stereotactic biopsy. Use of CD45 immunocytochemistry marker on squash smear would help in further selection of markers to specify lymphoma.
| Acknowledgment|| |
The authors would like to thank Dr. Laxmi Rao, Professor and HOD, Department of Pathology, Kasturba Medical College, Manipal, Karnataka, India for providing immunohistochemistry slides of the case.
| References|| |
|1.||Sierra del Rio M, Rousseau A, Soussain C, Ricard D, Hoang-Xuan K. Primary CNS lymphoma in immunocompetent patients. Oncologist 2009;14:526-39. |
|2.||Herrlinger U, Schabet M, Bitzer M, Petersen D, Krauseneck P. Primary central nervous system lymphoma: From clinical presentation to diagnosis. J Neurooncol 1999;43:219-26. |
|3.||Sarkar C, Sharma MC, Deb P, Singh R, Santosh V, Shankar SK. Primary central nervous system lymphoma: A hospital based study of incidence and clinicopathological features from India (1980-2003). J Neurooncol 2005;71:199-204. |
|4.||Koeller KK, Smirniotopoulos JG, Jones RV. Primary central nervous system lymphoma: Radiologic-pathologic correlation. Radiographics 1997;17:1497-526. |
|5.||Haque S, Law M, Abrey LE, Young RJ. Imaging of lymphoma of the central nervous system, spine, and orbit. Radiol Clin North Am 2008;46:339-61. |
|6.||Elder JB, Chen TC. Surgical interventions for primary central nervous system lymphoma. Neurosurg Focus 2006;21:E13. |
|7.||Mi W, Mittal S. Primary lymphoma of the central nervous system in an immunocompetent patient. Hosp Physician 2001;34-8. |
|8.||Alécio-Mattei T, Alécio-Mattei J, Aguiar PH, Ramina R. Primary central nervous system lymphomas in immunocompetent patients. Neurocirugia (Astur) 2006;17:46-53. |
|9.||Eichler AF, Batchelor TT. Primary central nervous system lymphoma: Presentation, diagnosis and staging. Neurosurg Focus 2006;21:E15. |
|10.||Joseph JT. Hematological tumors. In: Diagnostic Neuropathology Smears. Philadelphia: Lippincott Williams and Wilkins; 2006. p. 145-64. |
|11.||Makhdoomi R, Nayil K, Rayees A, Kirmani A, Ramzan A, Khalil MB, et al. Primary CNS lymphoma in immunocompetent: A review of literature and our experience from Kashmir. Turk Neurosurg 2011;21:39-47. |
|12.||Yamanaka R. Primary central nervous system lymphoma-Recent advance on clinical research. In: Lichtor T, editor. Clinical Management and Evolving Novel Therapeutic Strategies for Patients with Brain Tumours: InTech; 2013. Available from: http://www.intechopen.com/books/clinical-management-and-evolving-novel-therapeutic-strategies-for-patients-with-brain-tumours/primary-central-nervous-system-lymphoma-recent-advance-on-clinical-research [Last accessed on 2013 May 10]. |
|13.||Ferry JA. Lymphomas of the nervous system and the meninges. In: Ferry JA, editor. Extranodal Lymphomas. Philadelphia: Elsevier Saunders; 2011. p. 7-33. |
|14.||Buccoliero AM, Castiglione F, Caldarella A, Rossi Degl′Innocenti D, Taddei A, Ammannati F, et al. BCL-2 in primary central nervous system lymphomas. Immunohistochemistry and molecular biology. Pathologica 2004;96:425-9. |
[Figure 1], [Figure 2], [Figure 3], [Figure 4]